The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,670.00
Bid: 2,080.00
Ask: 1,387.00
Change: -63.50 (-3.66%)
Spread: -693.00 (-33.317%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

May And Trump To Co-Host Meeting With UK And US Business Leaders

Tue, 04th Jun 2019 07:28

LONDON (Alliance News) - Prime Minister Theresa May and US President Donald Trump will co-host a meeting of British and American business leaders in a bid to boost trade.

The prime minister plans to use the round table event on Tuesday to strengthen economic ties between the two countries.

The gathering at St James' Palace is also due to be attended by the Duke of York, Chancellor of the Exchequer Philip Hammond and International Trade Secretary Liam Fox.

US Secretary of State Mike Pompeo, US Secretary of the Treasury Steven Mnuchin and the president's daughter and assistant Ivanka Trump are expected at the meeting.

The gathering will bring together 10 leading companies, five from each nation, to discuss business opportunities and look at sectors where expanding links would benefit both sides.

Discussions are expected to focus on research, development and innovation, investment in infrastructure, and the scope for closer partnership in regulation and financial services.

Chief executives and senior representatives from BAE Systems PLC, GlaxoSmithKline PLC, National Grid PLC, Barclays PLC, Reckitt Benckiser Group PLC, JP Morgan Chase & Co, Lockheed Martin, Goldman Sachs International, Bechtel and Splunk are due to attend.

Referring to the UK-US economic relationship, the prime minister is expected to tell the meeting: "It is a great partnership, but one I believe we can make greater still.

"With a bilateral free trade agreement, with broader economic co-operation, and by continuing to work together to underpin, shape and influence the global economy and its rules and institutions – keeping markets free, fair and open, and keeping our industries competitive.

"There are opportunities to seize, and there are challenges we need to work together to tackle. Today, let us look at how we do both.

"Through dialogue like this we can ensure that our economic partnership not only endures but continues to grow stronger for many years to come – making our businesses more competitive, and creating jobs, opportunity and prosperity for all our people."

Emma Walmsley, chief executive of GSK, said: "The US is one of the most important sources of healthcare innovation in the world.

"Life sciences is also a strategic strength for the UK and there is a great opportunity for us to partner further to retain and accelerate both countries' global leadership in this sector, generating better outcomes for patients and economic growth on both sides of the Atlantic."

Roger Carr, chairman of BAE Systems, said: "Our relationship with the US of America is long-standing and operates to our mutual benefit on the firm foundation of trust, transparency and true partnership."

The US is Britain's single biggest business partner, with trade between the two countries worth GBP190 billion in 2018.

By Shaun Connolly, Press Association Political Correspondent

source: Press Association

More News
3 Apr 2024 21:37

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Read more
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.